Integrated Proteins Intrinsic Value
Integrated Proteins (INTEGFD) median intrinsic value is ₹50.00 from 7 valuation models (range ₹33–₹65), vs current price ₹84.66 — -40.9% downside (Trading Above Calculated Value), margin of safety -69.3%. For current market price and key ratios, visit INTEGFD stock live price.
INTEGFD Valuation Methods Summary — DCF, Graham Number & P/E
Integrated Proteins intrinsic value across 7 models vs current price ₹84.66 — upside/downside and value range per method. Browse INTEGFD quarterly financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹45.60 | ₹36.48 - ₹54.72 | -46.1% | EPS: ₹3.80, Sector P/E: 12x |
| Book Value Method | asset | ₹50.00 | ₹45.00 - ₹55.00 | -40.9% | Book Value/Share: ₹50.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.00 | ₹46.80 - ₹57.20 | -38.6% | Revenue/Share: ₹65.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹33.86 | ₹30.47 - ₹37.25 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹60.80 | ₹54.72 - ₹66.88 | -28.2% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹32.68 | ₹29.41 - ₹35.95 | -61.4% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹65.38 | ₹58.84 - ₹71.92 | -22.8% | EPS: ₹3.80, BVPS: ₹50.00 |
INTEGFD Intrinsic Value vs Market Price — All Valuation Models
Integrated Proteins fair value range ₹33–₹65 vs current market price ₹84.66 across 7 valuation models. Compare with Integrated Proteins value estimation to assess whether the stock is under or overvalued.
INTEGFD Intrinsic Value Analysis — Undervalued or Overvalued?
Integrated Proteins median intrinsic value ₹50.00, current price ₹84.66 — Trading Above Calculated Value by 40.9%, margin of safety -69.3%.
What is the intrinsic value of INTEGFD?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Integrated Proteins (INTEGFD) is ₹50.00 (median value). With the current market price of ₹84.66, this represents a -40.9% variance from our estimated fair value.
The valuation range spans from ₹32.68 to ₹65.38, indicating ₹32.68 - ₹65.38.
Is INTEGFD undervalued or overvalued?
Based on our multi-method analysis, Integrated Proteins (INTEGFD) appears to be trading above calculated value by approximately 40.9%.
INTEGFD Financial Health — Key Ratios vs Industry Benchmarks
Integrated Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.60 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | -99.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INTEGFD Cash Flow Quality — Operating & Free Cash Flow
Integrated Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-24 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |